Late stage investors in Massachusetts, United States
Updated 16 Nov 2026
Venture funds
5 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Wellington Management Wellington Management is an investment manager serving institutional clients, with recent investments including Tabby and Current. Boston, United States |
Fintech, Health care | Early stage venture, Late stage venture | 33% | 4 |
| 2 | Battery Ventures Battery Ventures invests in technology through private equity and venture capital, with recent investments including Orkes and LinearB. Boston, United States |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 39% | 3 |
| 3 | Founder Collective Founder Collective backs seed-stage startups, with recent investments including Baselayer, WHOOP and Ownwell. Cambridge, United States |
Artificial intelligence, Commerce | Seed, Early stage venture, Late stage venture | 6% | 2 |
| 4 | Polaris Partners Polaris Partners invests in healthcare and biotechnology companies, including Faro AI and Triveni Bio. Boston, United States |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 29% | 2 |
| 5 | Summit Partners Summit Partners invests in growth equity, fixed income and public equity, with recent backings including Hyperlight and NinjaOne. Boston, United States |
Hardware, Commerce | Seed, Early stage venture, Late stage venture | 35% | 2 |
Table 1. Late stage investors in Massachusetts, United States: venture capital and micro VC funds ranked by companies whose Series C and later round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Polaris Partners | Private equity firm | Boston, United States | •••@polarispartners.com | +1 855••• |
| Atlas Venture | Venture capital firm | Cambridge, United States | •••@atlasventure.com | 857 20••• |
| RA Capital Management | Startup incubator | Boston, United States | •••@racap.com | 617.77••• |
| Founder Collective | Venture capital firm | Cambridge, United States | •••@foundercollective.com | (617) ••• |
| F-Prime | Venture capital firm | Cambridge, United States | •••@fprimecapital.com | |
| Highland Capital Partners | Venture capital firm | Lexington, United States | •••@hcp.com | (781) ••• |
| MassVentures | Venture capital firm | Boston, United States | •••@mass-ventures.com | +1 617••• |
| North Bridge Venture Partners & Growth Equity | Venture capital firm | Wellesley, United States | •••@northbridge.com | 781.29••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| Battery Ventures | D••• T••• | General Partner | d•••@battery.com | In the CSV |
| Polaris Partners | J••• F••• | Founding Partner | j•••@polarispartners.com | In the CSV |
| Atlas Venture | B••• B••• | Partner | b•••@atlasventure.com | In the CSV |
| RA Capital Management | P••• K••• | Managing Partner | p•••@racap.com | In the CSV |
| Founder Collective | A••• H••• | General Partner | a•••@foundercollective.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 178 of the 285 late stage investors in Massachusetts, United States have a published email address, 158 a phone number and 259 a website.
- Battery Ventures has the most recorded investments, 923, 363 of them as lead investor.
- 48 of them are investors in at least one company that closed its most recent round in the last 12 months.
- RA Capital Management is an investor in 9 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Delix Therapeutics' $100.0M Series C on 9 November 2026.
- Software is the most common sector across their 1,737 portfolio companies (75%).
- Early stage venture is the most common investment stage, recorded for 246 of them (86%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Late stage investors in Massachusetts, United States
30 of 285, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Battery Ventures | Venture capital firm | Boston, United States | Hardware, Artificial intelligence | Flash, Nexite, Orkes | 5 | 923 | 363 | 242 | (415) ••• | In the CSV | |
| 2 | Polaris Partners | Private equity firm, Venture capital firm | Boston, United States | Health care, Artificial intelligence | Faro AI, Triveni Bio, Whisker Labs | 3 | 754 | 215 | 207 | •••@polarispartners.com | +1 855••• | In the CSV |
| 3 | Atlas Venture | Venture capital firm | Cambridge, United States | Health care, Biotech | Diagonal Therapeutics | 1 | 638 | 179 | 199 | •••@atlasventure.com | 857 20••• | In the CSV |
| 4 | Fidelity | Investment bank | Boston, United States | Health care, Hardware | Zipline International, Tenstorrent, SiMa.ai | 7 | 586 | 178 | 285 | +1-866••• | In the CSV | |
| 5 | RA Capital Management | Startup incubator, Private equity firm | Boston, United States | Health care, Biotech | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics | 9 | 544 | 183 | 243 | •••@racap.com | 617.77••• | In the CSV |
| 6 | Founder Collective | Venture capital firm | Cambridge, United States | Artificial intelligence, Commerce | Baselayer, WHOOP, Ownwell | 5 | 543 | 35 | 161 | •••@foundercollective.com | (617) ••• | In the CSV |
| 7 | F-Prime | Venture capital firm | Cambridge, United States | Health care, Fintech | T-Therapeutics, Albert Invent, Immuneel Therapeutics | 4 | 540 | 133 | 113 | •••@fprimecapital.com | In the CSV | |
| 8 | Highland Capital Partners | Venture capital firm | Lexington, United States | Hardware, Commerce | Tomorrow.io | 1 | 507 | 157 | 154 | •••@hcp.com | (781) ••• | In the CSV |
| 9 | MassVentures | Venture capital firm | Boston, United States | Health care, Hardware | Emvolon, ZwitterCo, Kytopen | 6 | 476 | 122 | 83 | •••@mass-ventures.com | +1 617••• | In the CSV |
| 10 | Summit Partners | Private equity firm, Venture capital firm | Boston, United States | Hardware, Commerce | Hyperlight, NinjaOne | 2 | 451 | 157 | 277 | +1 617••• | In the CSV | |
| 11 | North Bridge Venture Partners & Growth Equity | Venture capital firm | Wellesley, United States | Hardware, Commerce | Clothia, Ravel Law, Oracle Dyn | 425 | 134 | 120 | •••@northbridge.com | 781.29••• | In the CSV | |
| 12 | Accomplice | Family office, Venture capital firm | Cambridge, United States | Fintech, Artificial intelligence | Veera | 1 | 386 | 101 | 88 | •••@accomplice.co | 617-58••• | In the CSV |
| 13 | Sigma Partners | Venture capital firm | Boston, United States | Hardware, Commerce | High Street Partners, doxo, Volt Active Data | 345 | 95 | 85 | 650.85••• | In the CSV | ||
| 14 | Wellington Management | Private equity firm, Venture capital firm | Boston, United States | Fintech, Health care | Tabby, Current, Element Biosciences | 4 | 335 | 111 | 160 | •••@wellington.com | 617-95••• | In the CSV |
| 15 | SV Health Investors | Private equity firm, Venture capital firm | Boston, United States | Health care, Biotech | Alchemab Therapeutics | 1 | 325 | 76 | 95 | •••@svlsa.com | +1 617••• | In the CSV |
| 16 | TA Associates | Private equity firm | Boston, United States | Hardware, Artificial intelligence | Wunder Mobility, Stackline, Thinkproject | 317 | 173 | 194 | +1.617••• | In the CSV | ||
| 17 | MPM Capital | Private equity firm, Venture capital firm | Boston, United States | Biotech, Health care | Reunion Neuroscience, Umoja Biopharma, āshibio | 301 | 97 | 105 | •••@mpmcapital.com | +1 617••• | In the CSV | |
| 18 | Flagship Pioneering | Venture capital firm | Cambridge, United States | Biotech, Health care | Inari, Prologue Medicines, Quotient Therapeutics | 288 | 104 | 72 | 617-86••• | In the CSV | ||
| 19 | Cormorant Asset Management | Hedge fund | Boston, United States | Health care, Biotech | Triveni Bio, Third Arc Bio, BlossomHill Therapeutics | 4 | 276 | 58 | 141 | In the CSV | ||
| 20 | HarbourVest Partners | Private equity firm | Boston, United States | Fintech, Hardware | Varo Bank | 1 | 273 | 52 | 147 | •••@harbourvest.com | +1 617••• | In the CSV |
| 21 | Advent International | Private equity firm | Boston, United States | Fintech, Hardware | Coralogix, KreditBee | 2 | 234 | 97 | 89 | •••@adventinternational.com | 212 81••• | In the CSV |
| 22 | SR One | Venture capital firm | Cambridge, United States | Biotech, Health care | Asceneuron | 214 | 69 | 69 | (610) ••• | In the CSV | ||
| 23 | .406 Ventures | Venture capital firm | Boston, United States | Health care, Cybersecurity | InStride Health, FamilyWell Health | 2 | 211 | 66 | 39 | •••@406ventures.com | (617) ••• | In the CSV |
| 24 | Globespan Capital Partners | Venture capital firm | Boston, United States | Hardware, Commerce | Rev, Pursway, PerkStreet Financial | 202 | 54 | 70 | •••@globespancapital.com | 617.30••• | In the CSV | |
| 25 | Bain Capital | Private equity firm, Venture capital firm | Boston, United States | Fintech, Hardware | Mintlify | 1 | 198 | 89 | 89 | •••@baincapital.com | +1 617••• | In the CSV |
| 26 | Morningside | Family office, Startup incubator | Newton Center, United States | Commerce, Fintech | CloudMosa, Kuaidian Yuedu, Gaosi Education Group | 182 | 60 | 40 | •••@morningside.com | (617) ••• | In the CSV | |
| 27 | Omega Funds | Secondary purchaser, Venture capital firm | Boston, United States | Biotech, Health care | FoRx Therapeutics | 1 | 161 | 37 | 75 | •••@omegafunds.net | In the CSV | |
| 28 | Adage Capital Management | Government investment office | Boston, United States | Artificial intelligence, Health care | Welldoc | 161 | 13 | 119 | •••@adagecapital.com | 617-86••• | In the CSV | |
| 29 | Prism Venture Management | Venture capital firm | Needham, United States | Commerce, Hardware | Covera Health, Aigens, Connotate | 159 | 50 | 45 | •••@prismventure.com | 781.30••• | In the CSV | |
| 30 | Third Rock Ventures | Venture capital firm | Boston, United States | Biotech, Health care | Terremoto Biosciences | 1 | 154 | 69 | 44 | •••@thirdrockventures.com | (415) ••• | In the CSV |
Table 2. Late stage investors in Massachusetts, United States: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 285.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | RA Capital Management | Boston, United States | 9 | 47 | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics |
| 2 | Fidelity | Boston, United States | 7 | 40 | Zipline International, Tenstorrent, SiMa.ai |
| 3 | MassVentures | Boston, United States | 6 | 35 | Emvolon, ZwitterCo, Kytopen |
| 4 | Founder Collective | Cambridge, United States | 5 | 119 | Baselayer, WHOOP, Ownwell |
| 5 | Battery Ventures | Boston, United States | 5 | 165 | Flash, Nexite, Orkes |
| 6 | F-Prime | Cambridge, United States | 4 | 75 | T-Therapeutics, Albert Invent, Immuneel Therapeutics |
| 7 | Flare Capital Partners | Boston, United States | 4 | 21 | Suki, Photon, Qualified Health |
| 8 | Mission BioCapital | Cambridge, United States | 4 | 8 | Circle Pharma, Cloverleaf Bio, Integrated Biosciences |
| 9 | Wellington Management | Boston, United States | 4 | 39 | Tabby, Current, Element Biosciences |
| 10 | Cormorant Asset Management | Boston, United States | 4 | 13 | Triveni Bio, Third Arc Bio, BlossomHill Therapeutics |
| 11 | HighSage Ventures | Boston, United States | 3 | 7 | Avante AI, Archera, JuliaHub |
| 12 | MassMutual Ventures | Boston, United States | 3 | 24 | IMMIX, nyra health, CloudSEK |
| 13 | IGNIA | Boston, United States | 3 | 20 | Kontempo, Reuse, aviva |
| 14 | Polaris Partners | Boston, United States | 3 | 73 | Faro AI, Triveni Bio, Whisker Labs |
| 15 | Link Ventures | Cambridge, United States | 3 | 14 | Enlaye, Blitzy, Dono |
Table 3. Late stage investors in Massachusetts, United States: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | RA Capital Management | 11 to 50 | 2019 |
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | Fidelity | 1,001 to 5,000 | 2011 |
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | F-Prime | 51 to 100 | 2022 |
| Avante AI | Avante AI is an artificial intelligence platform that manages employee benefits for businesses. | Artificial intelligence | Seattle, United States | Series A | $30.0M | 2026-10-27 | $40.0M | HighSage Ventures | 11 to 50 | 2023 |
| Emvolon | Emvolon converts wasted resources into low-cost green fuels. | Energy | Woburn, United States | Series A | $22.0M | 2026-10-27 | $24.5M | MassVentures | 11 to 50 | 2021 |
| Archera | Archera helps organizations manage cloud and AI infrastructure costs with cost management software and financial protection services. | Artificial intelligence | Bellevue, United States | Series C | $15.0M | 2026-10-27 | $42.3M | HighSage Ventures | 51 to 100 | 2019 |
| Tenstorrent Unicorn | Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. | Artificial intelligence | Santa Clara, United States | Series E | $1.5B | 2026-10-19 | $2.5B | Fidelity | 501 to 1,000 | 2016 |
| Sirona Medical | Sirona Medical develops cloud-native radiology workflow software for medical imaging practices. | Artificial intelligence | San Francisco, United States | Series D | $40.0M | 2026-10-15 | $144.5M | Rose Park Advisors | 101 to 250 | 2018 |
| Liqid | Liqid sells composable infrastructure software that lets users configure, scale, and manage bare-metal servers. | Artificial intelligence | Westminster, United States | Series B | $26.9M | 2026-10-14 | $246.5M | Rose Park Advisors | 51 to 100 | 2013 |
| Albert Invent | Albert Invent builds an AI platform that supports chemistry research and development for scientific and industrial users. | Artificial intelligence | Oakland, United States | Series B | $55.0M | 2026-10-13 | $105.0M | F-Prime | 101 to 250 | 2022 |
Table 4. Late stage investors in Massachusetts, United States: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 1,297 | 75% |
| Health care | 349 | 20% |
| Hardware | 310 | 18% |
| Artificial intelligence | 285 | 16% |
| Fintech | 220 | 13% |
| Biotech | 192 | 11% |
| Commerce | 177 | 10% |
| Cybersecurity | 136 | 8% |
| Education | 58 | 3% |
| Energy | 28 | 2% |
Table 5. Late stage investors in Massachusetts, United States: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Late stage investors | 285 | 100% |
| Early stage investors | 246 | 86% |
| Seed investors | 138 | 48% |
| Venture investors | 115 | 40% |
| Private equity investors | 93 | 33% |
| Debt investors | 44 | 15% |
| Post IPO investors | 40 | 14% |
| Convertible note investors | 23 | 8% |
Table 6. Late stage investors in Massachusetts, United States by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Late stage investors in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 19 | 8% |
| 2010s | 76 | 32% |
| 2000s | 59 | 24% |
| 1990s | 38 | 16% |
| 1980s | 33 | 14% |
| 1970s | 8 | 3% |
Table 8. Late stage investors in Massachusetts, United States by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include late stage investors and its headquarters is in Massachusetts, United States. On 16 November 2026 that is 285 investors.
- 178 rows carry an email address and 158 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 285 rows: 26 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many late stage investors in Massachusetts, United States are on the list?
- 285, in the file dated 16 November 2026. 48 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 178 of the 285 carry an email address in the download and 158 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 285 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 285 rows, 178 firm email addresses and 158 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 127 of the 178 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.